182 related articles for article (PubMed ID: 28981818)
21. Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan.
Ma E; Shimazu T; Song M; Charvat H; Sawada N; Yamaji T; Inoue M; Camargo MC; Kemp TJ; Pfeiffer RM; Pinto LA; Rabkin CS; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):236-241. PubMed ID: 34697062
[TBL] [Abstract][Full Text] [Related]
22. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.
Cook MB; Barnett MJ; Bock CH; Cross AJ; Goodman PJ; Goodman GE; Haiman CA; Khaw KT; McCullough ML; Newton CC; Boutron-Ruault MC; Lund E; Rutegård M; Thornquist MD; Spriggs M; Giffen C; Freedman ND; Kemp T; Kroenke CH; Le Marchand L; Park JY; Simon M; Wilkens LR; Pinto L; Hildesheim A; Campbell PT
Gut; 2019 Jun; 68(6):960-968. PubMed ID: 30121626
[TBL] [Abstract][Full Text] [Related]
23. Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four cohort studies.
Sanikini H; Yuan JM; Butler LM; Koh WP; Gao YT; Steffen A; Johansson M; Vineis P; Goodman GE; Barnett MJ; Hung RJ; Chen C; Stücker I
BMC Cancer; 2018 Feb; 18(1):220. PubMed ID: 29471809
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein and risk of lung cancer.
Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
[TBL] [Abstract][Full Text] [Related]
25. Associations between Longer Leukocyte Telomere Length and Increased Lung Cancer Risk among Never Smokers in Urban China.
Wong JYY; Shu XO; Hu W; Blechter B; Shi J; Wang K; Cawthon R; Cai Q; Yang G; Rahman ML; Ji BT; Gao Y; Zheng W; Rothman N; Lan Q
Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1734-1737. PubMed ID: 37721487
[TBL] [Abstract][Full Text] [Related]
26. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
27. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
28. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917
[TBL] [Abstract][Full Text] [Related]
29. Circulating soluble cytokine receptors and colorectal cancer risk.
Ho GY; Wang T; Zheng SL; Tinker L; Xu J; Rohan TE; Wassertheil-Smoller S; Xue X; Augenlicht LH; Peters U; Phipps AI; Strickler HD; Gunter MJ; Cushman M
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):179-88. PubMed ID: 24192010
[TBL] [Abstract][Full Text] [Related]
30. Associations Between Macrophage Colony-Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First-Time Coronary Events: A Nested Case-Control Study.
Schiopu A; Bengtsson E; Gonçalves I; Nilsson J; Fredrikson GN; Björkbacka H
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625345
[TBL] [Abstract][Full Text] [Related]
31. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
Grote VA; Kaaks R; Nieters A; Tjønneland A; Halkjær J; Overvad K; Skjelbo Nielsen MR; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Becker S; Pischon T; Boeing H; Trichopoulou A; Cassapa C; Stratigakou V; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Sánchez MJ; Dorronsoro M; Navarro C; Gurrea AB; Siersema PD; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen NE; Travis RC; Fedirko V; Jenab M; Michaud DS; Chuang SC; Romaguera D; Bueno-de-Mesquita HB; Rohrmann S
Br J Cancer; 2012 May; 106(11):1866-74. PubMed ID: 22617158
[TBL] [Abstract][Full Text] [Related]
32. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
[TBL] [Abstract][Full Text] [Related]
33. Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women.
Wong HL; Rabkin CS; Shu XO; Pfeiffer RM; Cai Q; Ji BT; Yang G; Li HL; Rothman N; Gao YT; Zheng W; Chow WH
Cancer Sci; 2011 Oct; 102(10):1911-5. PubMed ID: 21740481
[TBL] [Abstract][Full Text] [Related]
34. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Lang Kuhs KA; Hildesheim A; Trabert B; Kemp TJ; Purdue MP; Wentzensen N; Katki HA; Pinto LA; Loftfield E; Safaeian M; Chaturvedi AK; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):825-32. PubMed ID: 25713025
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
[TBL] [Abstract][Full Text] [Related]
36. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
[TBL] [Abstract][Full Text] [Related]
37. Incidence trends and risk factors of lung cancer in never smokers: Pooled analyses of seven cohorts.
Rissanen E; Heikkinen S; Seppä K; Ryynänen H; Eriksson JG; Härkänen T; Jousilahti P; Knekt P; Koskinen S; Männistö S; Rahkonen O; Rissanen H; Malila N; Laaksonen MA; Pitkäniemi J;
Int J Cancer; 2021 Dec; 149(12):2010-2019. PubMed ID: 34398974
[TBL] [Abstract][Full Text] [Related]
38. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers.
Lim WY; Chen Y; Ali SM; Chuah KL; Eng P; Leong SS; Lim E; Lim TK; Ng AW; Poh WT; Tee A; Teh M; Salim A; Seow A
Carcinogenesis; 2011 Apr; 32(4):522-9. PubMed ID: 21252117
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD.
Jamal Jameel K; Gallert WJ; Yanik SD; Panek S; Kronsbein J; Jungck D; Koch A; Knobloch J
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
